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Abstract
Background: CVD risk factors (hypertension, dyslipidemia and diabetes) and MetS are closely related to obesity.
The selection of an optimal cut-off for various obesity indices is particularly important to predict CVD risk factors
and MetS.
Methods: Sixteen thousand seven hundred sixty-six participants aged 18–79 were recruited in Jilin Province in
2012. Five obesity indices, including BMI, WC, WHR, WHtR and BAI were investigated. ROC analyses were used to
evaluate the predictive ability and determine the optimal cut-off values of the obesity indices for CVD risk factors
and MetS.
Results: BMI had the highest adjusted ORs, and the adjusted ORs for hypertension, dyslipidemia, diabetes and MetS
were 1.19 (95 % CI, 1.17 to 1.20), 1.20 (95 % CI, 1.19 to 1.22), 1.12 (95 % CI, 1.10 to 1.13), and 1.40 (95 % CI, 1.38 to
1.41), respectively. However, BMI did not always have the largest adjusted AUROC. In general, the young
age group (18 ~ 44) had higher ORs and AUROCs for CVD risk factors and MetS than those of the other age
groups. In addition, the optimal cut-off values for WC and WHR in males were relatively higher than those in
females, whereas the BAI in males was comparatively lower than that in females.
Conclusions: The appropriate obesity index, with the corresponding optimal cut-off values, should be selected in
different research studies and populations. Generally, the obesity indices and their optimal cut-off values
are: BMI (24 kg/m2), WC (male: 85 cm; female: 80 cm), WHR (male: 0.88; female: 0.85), WHtR (0.50), and BAI
(male: 25 cm; female: 30 cm). Moreover, WC is superior to other obesity indices in predicting CVD risk factors and
MetS in males, whereas, WHtR is superior to other obesity indices in predicting CVD risk factors and MetS in females.
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Background
With economic development and the improvement of
living conditions, the prevalence of obesity is increasing
dramatically in China [1, 2]. A number of studies have
demonstrated that obesity is associated with hyperten-
sion, dyslipidemia, diabetes and MetS [3–5], and hyper-
tension, dyslipidemia and diabetes are considered risk
factors for CVD [6, 7].
To evaluate obesity, many indices have been proposed,
including BMI, WC, WHR, WHtR and BAI. Generally,
BMI is one of the most commonly used indices for obes-
ity, which approximates body mass using a mathematical
ratio of weight and height [8]. WC is the central diag-
nostic index of obesity and only considers abdominal
obesity [9]. WHR and WHtR are indices for evaluating
fat distribution using WC compared to HC or height
[10, 11]. Finally, BAI is an index to measure the amount
of body fat that uses HC compared to height [12]. Obvi-
ously, other indices may be used to measure obesity, but
we do not consider all of them here.
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Some studies indicated that WC or WHtR might be
better predictors for CVD risk factors or MetS in
Korean/Chinese populations [9, 13], whereas, Mbanya et
al. noted that WC was the best predictor in Cameroo-
nians [14]. Moreover, Bergman et al. found that BAI was
a better predictor for African-Americans and Mexican-
Americans [12], However, Lam et al. proposed that BAI
is not likely to be better than BMI and does not apply to
Asians [11]. Therefore, selection of the proper obesity
index for specific research and study populations was a
challenge.
In our study, the predictive ability and the optimal
cut-off values of five obesity indices (BMI, WC, WHR,
WHtR and BAI) for CVD risk factors and MetS are
comprehensively investigated. Data from 16,766 partici-
pants aged 18–79 in Jilin Province were used to evaluate
the obesity indices. Jilin is in central northeast China
and has an annual average temperature 4.8 °C (latitude
40° ~ 46°, longitude 121° ~ 131°) [15]. Therefore, the re-
sults can be instructive and meaningful for studies re-
lated to obesity in northeast China. WC and WHtR are
superior to other obesity indices in predicting CVD risk
factors and MetS in our study, with optimal cut-off




A large-scale cross-sectional survey was implemented in
Jilin Province in 2012. A total of 16,766 participants who
had lived in Jilin Province for more than 6 months and
were 18–79 years old were selected through multistage
stratified random cluster sampling (see details in Part 1
of the Additional file 1).
Data measurement
Height, weight, WC and HC were measured according
to a standardized protocol and techniques, with the par-
ticipants wearing light clothing but no shoes. Blood
pressure was measured by trained professionals using a
mercury sphygmomanometer. After an overnight fast,
FBG and serum lipids were measured before breakfast
using a Bai Ankang fingertip blood glucose monitor
(Bayer, Leverkusen, Germany) and a MODULE P800
biochemical analysis machine (Roche Co., Ltd.,
Shanghai, China), respectively (see details in Part 2 of
the Additional file 1).
The various obesity indices were calculated as follows:
BMI ¼ weight kgð Þ
height2 mð Þ ;WHR ¼
WC cmð Þ
HC cmð Þ ;
WHtR ¼ WC cmð Þ
height cmð Þ ;BAI ¼
HC cmð Þ
height1:5 mð Þ ‐18
Assessment criteria
CVD risk factors refer to hypertension, dyslipidemia and
diabetes in our study. Hypertension was defined as rest-
ing SBP ≥140 mmHg and/or DBP ≥ 90 mmHg and/or by
the use of antihypertensive medication in the past two
weeks [16]. Dyslipidemia was defined as use of lipid-
lowering drugs or having one or more of the following:
TG ≥ 1.7 mmol/L, TC ≥ 5.2 mmol/L, HDL-C < 1.0 mmol/
L and LDL-C ≥ 3.4 mmol/L [17]. Diabetes was defined
as the use of hypoglycemic agents or a self-reported his-
tory of diabetes or FBG of 7.0 mmol/L or more [18].
MetS [19, 20] was defined as three or more of the
following conditions clustered in one subject: a) WC ≥
85 cm for males or ≥ 80 cm for females; b) TG ≥
1.7 mmol/L or ongoing hypertriglyceridemia treatment;
c) HDL-C < 1.00 mmol/L for males or < 1.30 mmol/L for
females, or ongoing treatment; d) SBP ≥ 130 mmHg and
DBP ≥ 85 mmHg, or ongoing antihypertensive drug ther-
apy; and e) FBG ≥ 5.6 mmol/L or ongoing anti-diabetic
drug treatment.
Statistical analyses
The continuous variables were expressed as the means ±
standard deviations (SD) and compared using the t test.
The categorical variables were expressed as counts or
percentages and compared using the Rao-Scott-χ2 test.
ROC analyses were used to compare the predictive abil-
ity and determine the optimal cut-off values of the vari-
ous obesity indices for CVD risk factors and MetS [21].
The value that led to the maximum Youden index (SEN
+ SPE −1) [22] was taken as the optimal cut-off value,
and the AUROC was the index of the predictive ability.
Logistic regression models were used to calculate the
ORs and to evaluate the obesity indices. All statistical
analyses were performed using IBM SPSS 20.0. (SPSS
Inc., New York, NY, USA) Statistical significance was set
at a P value < 0.05.
Results
The characteristics of the participants are shown in
Table 1. Females had a higher age, TC, LDL-C and
HDL-C than males (P < 0.05), but other anthropomet-
ric indices were significantly higher in males than
those in females (P < 0.01). The prevalence of hyper-
tension, dyslipidemia, diabetes, and MetS differed sig-
nificantly by gender and were higher in males than in
females (P < 0.05).
For an overview of each obesity index, Table 2 presents
the adjusted ORs and AUROCs (adjusted for gender and
age). In general, BMI had the highest adjusted ORs for
CVD risk factors and MetS, but it did not always have
the largest adjusted AUROC. BMI, WC and WHtR had
the optimal adjusted AUROC for hypertension, whereas
WC, WHR and BMI had the largest adjusted AUROC
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for dyslipidemia, diabetes and MetS, respectively. More-
over, BAI did not have a better adjusted OR or AUROC
for any CVD risk factor or MetS in our study.
Then, the detailed performance of 5 obesity indices
associated with CVD risk factors and MetS was inves-
tigated. For females (Table 3), the ORs and AUROCs
of the obesity indices for CVD risk factors and MetS
were the largest in the 18 ~ 44 age group, followed by
the 45 ~ 64 group. Thus, obesity in the younger age
groups was at a higher risk for CVD risk factors and
MetS (higher ORs), and it had better predictive ability
for CVD risk factors and MetS as well (larger
AUROC). Further, the AUROC for males had a simi-
lar tendency and characteristics as that of females
(see Additional file 1: Table S3).
The detailed optimal operating points (OOPs) for
BMI, WC, WHR, WHtR and BAI to predict CVD risk
factors and MetS are given in Table 4, in which the OOP
is the cut-off value that leads to the maximum Youden
index (SEN + SPE −1) [22]. Obviously, the OOPs for dif-
ferent risk factors were different, so we chose a single
accessible value (close to the mean of the OOPs) as the
optimal cut-off value for each index. For example, the
OOPs of BMI for CVD risk factors and MetS ranged
from 23.24 to 24.48, so we chose 24 as the optimal cut-
off value for BMI, whereas the OOPs of WC ranged
from 84.13 to 85.74 for males and 79.32 to 81.58 for
females, so we chose 85 and 80 as the optimal WC
cut-off values. Similarly, the optimal cut-off value for
WHR was 0.88 and 0.85, for WHtR was 0.5, and for
BAI was 25 and 30, respectively. In addition, the opti-
mal cut-off values of BMI and WHtR were the same
in both genders, whereas the optimal cut-off values of
WC and WHR in males were relatively higher than
those in females, but the opposite occurred for BAI.
Generally, most of the optimal index cut-off values
were the same as or similar to other studies in litera-
ture [10, 11, 13, 23].
Table 1 Descriptive characteristics of the participants by gender
Variable All Male Female t/χ2 P value
(n = 16766) (n = 7697) (n = 9069)
Age(years) 47.80 ± 13.18 47.00 ± 13.74 48.47 ± 12.66 −7.20 <0.001
Height(cm) 162.84 ± 8.62 169.23 ± 6.59 157.41 ± 6.04 120.19 <0.001
Weight(kg) 64.49 ± 11.84 69.80 ± 11.91 59.98 ± 9.72 57.84 <0.001
WC(cm) 82.39 ± 10.52 84.70 ± 10.44 80.44 ± 10.19 26.58 <0.001
HC(cm) 95.08 ± 7.23 95.58 ± 7.2 94.66 ± 7.23 8.23 <0.001
SBP(mmHg) 131.35 ± 21.33 134.46 ± 19.75 128.71 ± 22.24 17.74 <0.001
DBP(mmHg) 80.01 ± 11.74 82.33 ± 11.73 78.04 ± 11.39 23.89 <0.001
TC(mmol/L) 4.90 ± 1.08 4.88 ± 1.06 4.92 ± 1.10 −2.50 0.012
TG(mmol/L) 1.96 ± 1.80 2.17 ± 2.09 1.79 ± 1.49 13.51 <0.001
LDL-C(mmol/L) 2.94 ± 0.89 2.89 ± 0.86 2.98 ± 0.92 −6.25 <0.001
HDL-C(mmol/L) 1.39 ± 0.39 1.35 ± 0.41 1.42 ± 0.36 −11.89 <0.001
FBG (mmol/L) 5.38 ± 1.66 5.52 ± 1.68 5.27 ± 1.64 9.94 <0.001
Hypertension 6249(37.27 %) 3162(41.08 %) 3087(34.04 %) 88.31 <0.001
Dyslipidemia 6679(39.76 %) 3410(44.30 %) 3269(36.05 %) 118.44 <0.001
Diabetes 1688(10.07 %) 820(10.65 %) 868(9.57 %) 5.39 0.02
MetS 5535(33.01 %) 2638(34.27 %) 2897(31.94 %) 10.21 0.001
Table 2 Adjusted ORs and adjusted AUROC for obesity indices in relation to CVD risk factors and MetS

















BMI 1.19(1.17,1.20) 0.77(0.76,0.78) 1.20(1.19,1.22) 0.71(0.70,0.72) 1.12(1.10,1.13) 0.73(0.72,0.74) 1.40(1.38,1.41) 0.81(0.80,0.81)
WC 1.06(1.06,1.07) 0.77(0.76,0.78) 1.08(1.07,1.08) 0.73(0.72,0.73) 1.05(1.05,1.06) 0.74(0.73,0.75) 1.15(1.14,1.16) 0.78(0.77,0.79)
WHR 1.08(1.07,1.09) 0.76(0.75,0.76) 1.12(1.11,1.12) 0.71(0.71,0.72) 1.08(1.07,1.09) 0.75(0.73,0.76) 1.19(1.18,1.20) 0.78(0.78,0.79)
WHtR 1.11(1.10,1.11) 0.77(0.76,0.78) 1.13(1.12,1.14) 0.72(0.71,0.73) 1.09(1.08,1.10) 0.74(0.73,0.75) 1.25(1.24,1.26) 0.79(0.78,0.80)
BAI 1.13(1.12,1.14) 0.75(0.74,0.76) 1.13(1.12,1.14) 0.66(0.65,0.67) 1.07(1.07,1.08) 0.71(0.70,0.72) 1.23(1.21,1.24) 0.75(0.74,0.76)
The OR and AUROC were adjusted for gender and age
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Table 3 ORs and AUROCs for the obesity indices in relation to CVD risk factors and MetS in females by age group
18 ~ 44 45 ~ 64 65 ~ 79
OR AUROC OR AUROC OR AUROC
Hypertension
BMI 1.23(1.20,1.26) 0.70(0.68,0.72) 1.17(1.15,1.19) 0.64(0.62,0.66) 1.11(1.07,1.16) 0.66(0.62,0.69)
WC 1.09(1.07,1.10) 0.70(0.68,0.72) 1.06(1.05,1.07) 0.64(0.62,0.66) 1.04(1.02,1.06) 0.65(0.61,0.69)
WHR 1.09(1.08,1.11) 0.69(0.67,0.71) 1.08(1.07,1.09) 0.63(0.61,0.65) 1.04(1.02,1.06) 0.64(0.60,0.68)
WHtR 1.14(1.12,1.16) 0.70(0.68,0.72) 1.10(1.09,1.12) 0.64(0.62,0.66) 1.06(1.04,1.09) 0.67(0.63,0.70)
BAI 1.17(1.14,1.20) 0.66(0.64,0.68) 1.12(1.10,1.14) 0.60(0.58,0.62) 1.07(1.03,1.11) 0.64(0.60,0.68)
Dyslipidemia
BMI 1.18(1.16,1.21) 0.74(0.72,0.76) 1.15(1.12,1.17) 0.71(0.69,0.72) 1.08(1.05,1.12) 0.69(0.65,0.72)
WC 1.07(1.06,1.08) 0.75(0.73,0.76) 1.06(1.06,1.07) 0.72(0.70,0.73) 1.05(1.03,1.06) 0.68(0.65,0.72)
WHR 1.10(1.08,1.11) 0.74(0.72,0.76) 1.10(1.08,1.11) 0.70(0.68,0.71) 1.06(1.04,1.09) 0.67(0.63,0.71)
WHtR 1.12(1.10,1.13) 0.75(0.73,0.77) 1.10(1.09,1.11) 0.71(0.70,0.73) 1.06(1.04,1.08) 0.68(0.64,0.71)
BAI 1.12(1.10,1.15) 0.68(0.67,0.70) 1.09(1.07,1.10) 0.63(0.62,0.65) 1.03(1.00,1.06) 0.60(0.56,0.64)
Diabetes
BMI 1.17(1.12,1.22) 0.65(0.61,0.70) 1.10(1.07,1.12) 0.62(0.59,0.64) 1.11(1.06,1.16) 0.62(0.57,0.67)
WC 1.08(1.06,1.10) 0.68(0.64,0.73) 1.05(1.04,1.06) 0.65(0.62,0.67) 1.04(1.02,1.06) 0.61(0.56,0.66)
WHR 1.10(1.07,1.14) 0.70(0.66,0.74) 1.10(1.08,1.11) 0.65(0.63,0.67) 1.03(1.01,1.06) 0.60(0.54,0.65)
WHtR 1.13(1.10,1.17) 0.69(0.65,0.74) 1.08(1.07,1.10) 0.64(0.61,0.66) 1.07(1.04,1.10) 0.61(0.56,0.66)
BAI 1.10(1.05,1.16) 0.63(0.58,0.67) 1.06(1.03,1.08) 0.56(0.54,0.59) 1.07(1.03,1.12) 0.56(0.51,0.61)
MetS
BMI 1.39(1.35,1.43) 0.84(0.82,0.85) 1.32(1.29,1.34) 0.80(0.78,0.81) 1.24(1.19,1.30) 0.79(0.76,0.82)
WC 1.17(1.15,1.18) 0.86(0.85,0.87) 1.13(1.12,1.14) 0.83(0.82,0.84) 1.10(1.08,1.12) 0.83(0.80,0.85)
WHR 1.18(1.16,1.20) 0.83(0.81,0.84) 1.17(1.15,1.18) 0.79(0.77,0.80) 1.11(1.08,1.13) 0.77(0.74,0.80)
WHtR 1.26(1.24,1.29) 0.85(0.84,0.86) 1.21(1.19,1.22) 0.81(0.80,0.83) 1.15(1.12,1.18) 0.81(0.78,0.84)
BAI 1.27(1.24,1.3) 0.75(0.73,0.77) 1.18(1.16,1.2) 0.69(0.68,0.71) 1.11(1.07,1.15) 0.69(0.65,0.73)
Table 4 Optimal operating points of the obesity indices for predicting CVD risk factors and MetS




























Hypertension 23.24 73.41 49.03 84.56 67.13 57.21 0.88 71.78 54.14 0.48 76.11 51.11 24.74 70.12 51.13
Dyslipidemia 23.81 72.29 61.01 84.13 70.19 64.64 0.88 72.32 59.87 0.49 74.04 60.62 24.83 69.14 53.18
Diabetes 24.46 63.72 56.18 85.74 69.13 56.32 0.89 71.14 57.43 0.50 74.28 51.21 25.11 67.79 47.81
MetS 24.48 78.10 70.47 84.92 88.62 70.71 0.88 82.31 64.76 0.51 80.54 72.04 25.10 74.63 58.42
Female
Hypertension 23.64 71.33 56.39 80.14 71.71 63.12 0.85 71.13 60.55 0.51 71.42 65.36 29.44 71.12 56.23
Dyslipidemia 23.25 75.17 51.12 79.32 72.62 58.81 0.84 72.22 57.68 0.50 73.83 58.87 29.12 69.73 51.22
Diabetes 24.47 63.42 58.17 81.58 71.88 58.59 0.86 74.83 61.42 0.52 77.34 56.69 30.35 59.14 58.54
MetS 24.16 77.13 66.76 79.86 90.47 66.47 0.85 79.54 65.83 0.51 84.39 68.03 29.29 77.82 55.63
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Finally, we investigated the adjusted ORs and AUROC
of each obesity index for CVD risk factors and MetS
(Table 5) using the optimal cut-off values determined
above. In general, the WC and WHtR had higher ad-
justed ORs and AUROCs for CVD risk factors and
MetS, regardless of the small difference between gen-
ders. WC was superior to other obesity indices in pre-
dicting CVD risk factors and MetS in males, but WHtR
was superior to other obesity indices in predicting CVD
risk factors and MetS in females. Abnormal WC or
WHtR was at a higher risk for CVD risk factors and
MetS, whereas WC and WHtR were superior to other
indices in predicting CVD risk factors and MetS.
Discussion
The prevalence of hypertension, dyslipidemia, diabetes
and MetS in our study were 37.27 %, 39.76 %, 10.07 %
and 33.1 %, respectively, much higher than those in
other studies [17]. It was believed that obesity was asso-
ciated with CVD risk factors and MetS [3] and various
obesity indices were used in literature [24, 25] to de-
scribe obesity. Unfortunately, no obesity index was con-
sistently superior in predicting CVD risk factors and
MetS, and the selection of an obesity index depended on
the study population and other factors [11]. Thus, in this
study, we investigated the proper obesity index and opti-
mal cut-off values to predict CVD risk factors and MetS
for a population in northeast China.
In this study, obesity in younger age groups was a
higher risk and had better predictive ability for CVD risk
factors and MetS than in older groups. It was implied
that obesity might have more influence on young people.
One possible reason was that the young people took part
in fewer outdoor activities and had worse eating habits
than the older people. Another possible reason was that
other factors might have larger effects on CVD risk fac-
tors and MetS than obesity among older people. It was
suggested that the younger the participant, the more
effective it is to control obesity.
We investigated the performance of five obesity indi-
ces (BMI, WC, WHR, WHtR and BAI) for CVD risk fac-
tors and MetS in northeast China. A series of optimal
cut-off values of each obesity index was determined in
our study, which could provide an instructive suggestion
in similar studies and populations. In summary, BMI,
WC and WHtR had the same optimal cut-offs as other
studies in China [13, 23], while the optimal cut-off value
of WHR was a little higher [13], and that of BAI was a
little lower than previous studies [12]. A probable reason
might be the characteristics of Asians (especially Asian
women), with smaller HC than Americans [26]. The
higher tolerance of WHR for CVD risk factors and MetS
might be due to the flexibility of fat for those in north-
east China under the long duration of cold weather.
Further, WC and WHtR were superior to other obesity
indices in our study, which was consistent with other
studies [27–32]. Moreover, the global cut-off value of
WHtR was 0.5, which implied that this criterion might
be applied to people in northeast China [10]. Meanwhile,
a number of meta-analyses on CVD risk factors out-
comes suggested that 0.5 (WHtR) could be appropriate
for different genders and age groups [24, 33]. Moreover,
the WGOC (Working Group on Obesity in China) de-
veloped a cut-off value for central obesity (85.0 cm for
male and 80.0 cm for female) using WC and overweight
status (24 kg/m2) using BMI for the general Chinese
Table 5 Adjusted ORs and AUROCs of the obesity indices associated with CVD risk factors and MetS


















A1 2.62(2.37,2.89) 0.61(0.59,0.62) 3.97(3.61,4.37) 0.65(0.65,0.67) 2.34(1.99,2.74) 0.60(0.58,0.61) 8.93(7.94,10.04) 0.74(0.73,0.75)
A2 2.65(2.40,2.93) 0.62(0.61,0.63) 4.21(3.82,4.63) 0.67(0.66,0.68) 2.81(2.36,3.35) 0.63(0.61,0.65) 15.81(13.94,17.92) 0.79(0.78,0.80)
A3 2.47(2.23,2.73) 0.63(0.62,0.64) 4.05(3.66,4.47) 0.66(0.65,0.67) 2.75(2.34,3.22) 0.63(0.62,0.65) 8.78(7.77,9.92) 0.73(0.72,0.74)
A4 2.70(2.45,2.99) 0.64(0.62,0.65) 4.14(3.75,4.56) 0.67(0.66,0.68) 2.58(2.19,3.04) 0.63(0.61,0.65) 11.36(10.06,12.84) 0.76(0.75,0.77)
A5 2.14(1.94,2.36) 0.61(0.59,0.62) 2.59(2.36,2.85) 0.62(0.60,0.63) 1.64(1.40,1.92) 0.57(0.56,0.59) 3.94(3.54,4.38) 0.66(0.65,0.67)
Female
A1 2.60(2.35,2.87) 0.64(0.62,0.65) 2.44(2.22,2.67) 0.63(0.62,0.64) 1.98(1.70,2.30) 0.61(0.59,0.63) 6.32(5.68,7.04) 0.72(0.71,0.70)
A2 2.86(2.58,3.17) 0.68(0.66,0.69) 2.71(2.46,2.98) 0.66(0.64,0.67) 2.53(2.13,2.99) 0.65(0.63,0.67) 11.53(10.20,13.03) 0.78(0.77,0.79)
A3 2.11(1.90,2.33) 0.66(0.65,0.67) 2.36(2.14,2.60) 0.65(0.64,0.66) 2.97(2.48,3.55) 0.67(0.65,0.69) 5.45(4.89,6.08) 0.72(0.71,0.74)
A4 2.82(2.53,3.14) 0.68(0.67,0.69) 2.83(2.56,3.14) 0.66(0.65,0.67) 2.99(2.46,3.63) 0.67(0.65,0.68) 10.75(9.40,12.30) 0.76(0.75,0.77)
A5 2.00(1.81,2.20) 0.63(0.62,0.64) 1.68(1.53,1.85) 0.60(0.59,0.61) 1.28(1.10,1.48) 0.58(0.56,0.60) 3.06(2.77,3.38) 0.67(0.65,0.68)
A1: BMI > 24 vs. ≤24 kg/m2, A2: WC > 85 vs. ≤85 (men) or WC > 80 vs. ≤80 (women), A3: WHR > 0.88 vs. ≤0.88 (men) or WHR > 0.85 vs. ≤0.85 (women), A4: WHtR
>0.5 vs. ≤0.5, A5: BAI > 25 vs. ≤25 (men) or BAI >30 vs. ≤30 (women). The OR and AUROC were adjusted for age
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population [34], which were coincident with those in
our study. In addition, other studies in Asian countries
reported cut-off values of WC for males and females of
approximately 80–85 and 75–80, respectively [35, 36],
that were similar to those in our study.
Here, we indicate the limitations of our study. First,
the definition of MetS overlapped with that of WC, so
the AUROC and adjusted ORs for MetS might be over-
estimated. Despite this, the optimal WC cut-off value
was consistent with the definition of MetS, which could
be viewed as evidence of the rationality of our study.
Second, gender and age were adjusted for in our study;
however, other confounders that might have impacts on
CVD risk factors and MetS, such as physical activity,
smoking, etc., were not under our consideration this
time, which might have some slight effect on our results.
Finally, we investigated the adjusted ORs of each
index, based on the proposed optimal cut-off values.
Generally, WC and WHtR were superior to other indices
(larger AUROC), and the people with abnormal WC or
WHtR were at higher risk (higher ORs) for CVD risk
factors and MetS. Obviously, both indices could measure
central obesity to some extent. Thus, it might be implied
that the distribution of fat was more important than the
amount of fat in predicting the risk for CVD risk factors
and MetS.
Conclusions
The proper obesity index should be selected in different
research studies and populations, with the correspond-
ing optimal cut-off values. Generally, the obesity indices
considered in our study and their optimal cut-off values
are: BMI (24 kg/m2), WC (male: 85 cm; female: 80 cm),
WHR (male: 0.88; female: 0.85), WHtR (0.50), and BAI
(male: 25 cm; female: 30 cm). Moreover, WC is superior
to other obesity indices in predicting CVD risk factors
and MetS in males, but WHtR is superior to other obes-
ity indices in predicting CVD risk factors and MetS in
females.
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